Windy City Media Group Frontpage News
Celebrating 30 Years of Gay Lesbian Bisexual and Trans News
home search facebook twitter join
Gay News Sponsor Windy City Times 2016-07-20
DOWNLOAD ISSUE
About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage


  WINDY CITY TIMES

Forum explores Truvada's use in fighting HIV
by Kate Sosin, Windy City Times
2011-06-22

facebook twitter pin it del.icio.us stumble upon digg google +1 reddit email


When Gladstone Institutes released evidence that Truvada, a one-a-day HIV pill, might prevent HIV in addition to treating it, the news sparked both excitement and skepticism.

The AIDS Healthcare Foundation (AHF), the largest HIV/AIDS medical provider in the country, came out against the use of Truvada for prevention, despite the fact that Gladstone's Iniciativa Profilaxis Preexposicion (iPrEx) trial showed the drugs to be more than 90-percent effective in preventing HIV in those who took it daily.

Experts on the study sat down with Feast of Fun podcasters Fausto FernÃ"s and Marc Felion at Center on Halsted June 15 to talk about what the study means and if Truvada could signal the end of the pandemic. Present were Dr. Robert Grant of Gladstone Institute, Keith Green, director of federal affairs at AIDS Foundation of Chicago, and a youth who participated in a similar study Green conducted in Chicago.

"In our wildest dreams, we did not think [Truvada] would be more than 90-percent effective in those who took it," Grant told the audience.

The findings also astounded Green, who halted Project PrEPare, a similar Chicago study, because he didn't want to continue administering placebos when he knew Truvada worked.

While the effectiveness of Truvada in preventing HIV is clear, the practicality of it remains uncertain. For one, Truvada is meant to be taken daily, which could pose a challenge to many not accustomed to the routine or whose lives don't always allow for consistency, such as youth living on the street. Additionally, Truvada is not without side effects including nausea, although that tends to go away over prolonged use, said Grant.

One barrier in getting people to use Truvada is stigma, Grant said.

"These pills, in particular, have been the one thing that folks want to avoid," he said, adding that fear surrounding HIV/AIDS contributes to fear around taking Truvada for prevention. "It strikes people as a misuse [of the drug]."

The drug could cost as much at $10,000 a year, an impossibly high price for people without insurance. In Illinois, the AIDS Drug Assistance Program (ADAP) which provides antiretrovirals to those who cannot afford them, is already cash-strapped. Truvada used for prevention could compete with Truvada treatments, creating a kind of Catch-22 for service providers who want to end the spread of HIV but also serve those who are positive already.

"We really have an ethical dilemma," Green said.

Still, many insurance companies are interested in Truvada for prevention because even with the cost of the drug, prevention is at least half the cost of treatment.

Rico, the youth who participated in Green's Chicago study on Truvada said that taking the drug made him "more considerate" of his body and protecting himself. He said that he had been hesitant to participate in the study but decided to sign up when he learned of the impact it could have on his community.

Grant and Green did acknowledge that iPrEx study had its shortcomings.

"I started to look at Dr. Grant's work, and those people didn't look like our people," Green said, adding that a low number of youth and African Americans had participated. Grant agreed and noted that their efforts would seek the expertise of Chicago service providers whose work included a diversity of clients. Still he added, the drug seemed to work equally well among people of every race.

As for AHF's critiques of using Truvada for prevention, neither Grant nor Green seemed to give them much weight.

"This is a large corporation, actually that has revenues above 300 million dollars a year, so well above my pay grade," said Grant, who went on to say that he was not certain about why AHF was working to discredit the trial results.

Truvada is awaiting FDA approval before it can be marketed for HIV prevention. Grant said that Gilead, the company that makes Truvada, will likely be hesitant to market the drug for prevention and that it will be up to AIDS service providers to make the leap in making Truvada more accessible.

For some, that leap can't come quickly enough.

"We either pay now or we pay forever," Grant said. "We have a chance now to stop this epidemic."


facebook twitter pin it del.icio.us stumble upon digg google +1 reddit email




Windy City Media Group does not approve or necessarily agree with the views posted below.
Please do not post letters to the editor here. Please also be civil in your dialogue.
If you need to be mean, just know that the longer you stay on this page, the more you help us.


  ARTICLES YOU MIGHT LIKE

New blood-donation rules for gay men slowly take effect 2016-07-20
Chicago House unveils new leaders 2016-07-20
AIDS Healthcare Foundation holds pre-RNC concert 2016-07-18
Report: No new transmissions between HIV-negative partners and people on HIV treatment 2016-07-15
'Art AIDS America' coming Dec. 1 2016-07-14
Health guide released for uninsured, underinsured 2016-07-13
Ride for AIDS culminates with emotional festival 2016-07-13
Center on Halsted still waiting on testing payments 2016-07-12
Chicago House announces new board members 2016-07-07
Circle Theatre's Full Circle Series It's a Privilege to Pee July 11 2016-07-02
Chicago Women's Health Center 4th Revolutionary Healthcare Fundraiser 2016-07-02
FAMILIES OF CHOICE SERIES Dr. Jesus Ramirez-Valles 2016-06-29
Pols push to end blood-donation policy 2016-06-29
Ride for AIDS Chicago: Fighting HIV/AIDS mile after mile 2016-06-29
Lurie Gender and Sex program receives Pritzker $500K matching gift 2016-06-25
GUEST COLUMN Know Your Rights: Combating Health Care Discrimination 2016-06-22
Nat'l HIV Testing Day June 27 2016-06-22
Panel examines challenges of HIV prevention 2016-06-21
Rep. Quigley, 114 Bipartisan House Members Push FDA to End Gay, Bi Blood Ban 2016-06-21
Panel examines gender and psychoanalysis 2016-06-19
AIDS @ 35: Gaylord discusses a life in "creative" activism 2016-06-19
LGBT Advocates Issue New Guidelines for Hospitals Treating Trans Patients 2016-06-19
AMA Urges Physician Education on Use of Once-A-Day HIV Prevention 2016-06-18
Groups host 'Black and Brown Town Hall' 2016-06-13
Newest edition of Red Ribbon Cash ticket unveiled 2016-06-13
Hinde reflects as she prepares to exit Heartland Health 2016-06-08
AIDS @ 35: Sean Strub speaks about the HIV/AIDS crisis 2016-06-08
CDPH receives $3 million grant for HIV prevention and care 2016-06-08
Obama statement on 35th anniversary of HIV/AIDS in America 2016-06-05
CNN's "The Eighties: The Fight Against AIDS" episode airs June 2 2016-06-01
Chicagoan among pharmacists' group's newest officers 2016-06-01
Longtime AIDS activist focuses on criminal-justice system 2016-06-01
Match website surveys LGBTQ singles 2016-05-26
Report: Southern MSM most at risk for HIV 2016-05-25
Group launches LGBTQ ads targeting Asian/Pacific Islander families 2016-05-25
Event to look at NY LGBTQ youth and survival sex 2016-05-25
Experts discuss online hookups at 'Out at CHM' 2016-05-25
Psychology grad conducts research on gay men's body image 2016-05-25
UN blocks orgs that rep trans people from AIDS meeting 2016-05-22
Enduring Love, gay couple copes with Alzheimer's 2016-05-18
 



Copyright © 2016 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 

 

 

TRENDINGBREAKINGPHOTOS

Sponsor
Sponsor
Sponsor
Sponsor
Sponsor
Sponsor


 



Sponsor

About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage



About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots      OUT! Guide     
Identity      BLACKlines      En La Vida      Archives      Subscriptions      Distribution      Windy City Queercast     
Queercast Archives      Advertising  Rates      Deadlines      Advanced Search     
Press  Releases      Event Photos      Join WCMG  Email List      Email Blast     
Upcoming Events      Todays Events      Ongoing Events      Post an Event      Bar Guide      Community Groups      In Memoriam      Outguide Categories      Outguide Advertisers      Search Outguide      Travel      Dining Out      Blogs      Spotlight  Video     
Classifieds      Real Estate      Place a  Classified     

Windy City Media Group produces Windy City Queercast, & publishes Windy City Times,
The Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community,
Nightspots, Out! Resource Guide, and Identity.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.

www.windycitymediagroup.com
[email protected]  •  [email protected]  •  [email protected]

Website Powered by LoveYourWebsite.com